Aditxt Inc   (ADTX)
Other Ticker:  
Price: $3.4100 $-0.08 -2.292%
Day's High: $3.49 Week Perf: -1.73 %
Day's Low: $ 3.39 30 Day Perf: -11.43 %
Volume (M): 29 52 Wk High: $ 76.40
Volume (M$): $ 100 52 Wk Avg: $16.26
Open: $3.47 52 Wk Low: $0.32

 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 0
 Employees -
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -30
 Cash Flow (TTM) (Millions $) -8
 Capital Exp. (TTM) (Millions $) 0

Aditxt Inc
Aditxt Inc is a biotechnology company based in the United States. The company specializes in developing innovative technologies and solutions in the field of health diagnostics. Aditxt focuses on leveraging its Immune Monitoring BioSensor Platform to develop advanced diagnostics tests that can provide information about an individual's immune system health. Their aim is to improve disease detection and monitoring, medication efficacy, and personalized medicine. The company's technology combines bioinformatics, immunology, and data science to provide insights into an individual's immune system functioning and overall health. Aditxt Inc aims to revolutionize the healthcare industry through its cutting-edge diagnostics solutions.

   Company Address: 737 N. Fifth Street Richmond 23219 VA
   Company Phone Number: 870-1200   Stock Exchange / Ticker: NASDAQ ADTX
   ADTX is expected to report next financial results on April 16, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Merger and Acquisition

Aditxt, Inc. Pioneers Personalized Neurological Care with New EEG Brain Monitoring Technologies

Published Tue, Jan 30 2024 1:30 PM UTC

Aditxt, Inc. Enhances Healthcare Innovations with Acquisition of EEG Brain Monitoring Technologies and Devices
Aditxt, Inc., a leading player in the biotechnology and personalized medicine sector, has recently made an exciting move by acquiring a portfolio of Electroencephalography (EEG) brain monitoring technologies and devices. The company's purchase includes NeuroCap...

Business Update

Aditxt Acquires Mitomic Testing Platform for $25M to Shape the Future of Disease and Cancer Detection Amid Increasing Revenue Growth

Published Mon, Jan 8 2024 1:30 PM UTC

The biotech sector continues to make breakthrough strides as Pearsanta, Inc., a subsidiary of Aditxt, Inc. (NASDAQ: ADTX), announced its acquisition of the proprietary early disease and cancer detection platform of MDNA Life Sciences Inc. This transaction is valued at approximately $25 million. Aditxt, Inc., a healthcare innovation firm dedicated to the discovery, developmen...

Stock Transactions

Aditxt Inc. Announces Successful Closure of $6 Million Private Placement, Boosting Shareholders' Confidence

Published Fri, Jan 5 2024 1:30 PM UTC

Aditxt Inc., a leading innovation company specializing in immune system monitoring and modulation technologies, has recently made headlines with its successful closure of a private placement for the purchase and sale of 1,237,114 shares of common stock at a purchase price of $4.85 per share. This move has had a significant impact on the company and its shareholders, rei...

Business Update

Aditxt, Inc Reinstated in Compliance with Nasdaq Stockholders Equity Requirement, Setting a Path to Growth

Published Tue, Jan 2 2024 1:30 PM UTC

Aditxt, Inc. Reinstated in Compliance with Nasdaq Stockholders Equity Requirement, Setting a Path to GrowthAditxt, Inc., a renowned health innovation company dedicated to discovering, developing, and deploying groundbreaking medical solutions, has overcome a crucial hurdle by regaining compliance with the minimum stockholders equity requirement set by The Nasdaq Stock Market...

Stock Transactions

Aditxt Expands Shareholder Base Through Strategic Purchase and Sale Agreement

Published Fri, Dec 29 2023 10:07 PM UTC

RICHMOND, Va. -- Aditxt, Inc. (NASDAQ: ADTX), a pioneering company focused on immune system monitoring and modulation technologies, has recently made a significant stride towards driving shareholder value. In a momentous development, Aditxt announced that it has entered into definitive agreements for the purchase and sale of 1,237,114 shares of common stock (or pre...


Aditxt Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com